Related Experiment Video
Updated: Nov 18, 2025
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Mixed Phenotype Acute Leukemia: Current Approaches to Diagnosis and Treatment
Thomas B Alexander1, Etan Orgel2
1University of North Carolina, 170 Manning Drive, 1185A Physicians Office Building, CB # 7236, Chapel Hill, NC, 27599, USA. talex@email.unc.edu.
Purpose Of Review:
Mixed phenotype acute leukemia (MPAL) is a rare subtype of acute leukemia with features of both acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). The review examines current definitions and controversies in classification of MPAL, new insights into genomic drivers and pathogenesis, recent evidence to support treatment recommendations, and opportunities for future research.
Recent Findings:
Recent collaborative efforts have made progress in understanding the genomic landscape and optimal therapy for MPAL. The preponderance of retrospective data supports beginning therapy with ALL directed regimens. Differences in prognosis for adult and children with MPAL have led to divergent approaches for therapy intensity, including use of stem cell transplantation consolidation. MPAL remains a challenging leukemia to understand, research, and treat due to low incidence, shifting and subjective approaches to classification, and innate biological heterogeneity. Ongoing research hopes to surmount these obstacles through prospective studies within large cooperative groups to provide new insight into targetable biology and further refine optimal therapy.
Insights
Mixed phenotype acute leukemia (MPAL) is a rare blood cancer. Current research focuses on its classification, genetics, and treatment, with ALL-directed regimens showing promise.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Mixed phenotype acute leukemia (MPAL) is a rare hematologic malignancy.
- MPAL exhibits characteristics of both acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
- Understanding MPAL is challenging due to its rarity and classification complexities.
Purpose of the Study:
- To review current MPAL classification systems and controversies.
- To explore novel insights into MPAL genomic drivers and pathogenesis.
- To evaluate evidence supporting MPAL treatment recommendations and identify future research directions.
Main Methods:
- Review of recent collaborative research efforts and retrospective data.
- Analysis of genomic landscape and therapeutic approaches for MPAL.
- Examination of prognostic differences between adult and pediatric MPAL patients.
Main Results:
- Progress has been made in understanding MPAL's genomic landscape and optimal therapy.
- Retrospective data suggest ALL-directed regimens as a primary treatment approach.
- Therapeutic intensity varies for adults and children, including stem cell transplantation.
Conclusions:
- MPAL presents significant challenges in research and treatment due to its heterogeneity and classification subjectivity.
- Prospective studies in cooperative groups are crucial for advancing MPAL understanding.
- Future research aims to uncover targetable biology and refine optimal MPAL therapy.
More Related Videos
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...